Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/26/18
End: 08/25/20
Due: 08/25/21
Phase: N/A
Priority: Normal
Start: 01/23/23
End: 10/30/24
Due: 10/30/25
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 12/22/23
Due: 12/22/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation | NCT03721328 | Osteal Therapeutics, Inc. | user2@example.com | None | 2018-10-26 | 2020-08-25 | 2021-08-25 | - | - | 2025-07-14 |
| A Second Trial of the Abbreviated Protocol Two-Stage Exchange | NCT05607030 | Osteal Therapeutics, Inc. | user2@example.com | None | 2023-01-23 | 2024-10-30 | 2025-10-30 | - | - | 2025-07-14 |
| Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty | NCT06383611 | Osteal Therapeutics, Inc. | user2@example.com | None | - | - | - | - | - | 2025-07-14 |
| Abbreviated Protocol for Two-Stage Exchange | NCT04662632 | Osteal Therapeutics, Inc. | user2@example.com | None | 2021-11-01 | 2023-12-22 | 2024-12-22 | - | - | 2025-07-14 |